Followers | 434 |
Posts | 57599 |
Boards Moderated | 5 |
Alias Born | 01/09/2007 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 07, 2010 5:34:22 PM
BY Midnight Trader
— 5:29 PM ET 09/07/2010
05:29 PM Eastern Daylight Time, 09/07/2010 (MidnightTrader) --
Bristol-Myers Squibb Company (BMY) and ZymoGenetics (ZGEN) have signed a definitive agreement providing for the acquisition of ZymoGenetics (ZGEN) by Bristol-Myers Squibb (BMY) for $9.75 per share in cash. The transaction, with an aggregate purchase price of approximately $885 million, or approximately $735 million net of cash acquired, has been unanimously approved by the boards of directors of both companies. The board of directors of ZymoGenetics (ZGEN) intends to recommend that ZymoGenetics' (ZGEN) shareholders tender their shares in the tender offer. In addition, shareholders holding approximately 37% of the outstanding shares of ZymoGenetics' (ZGEN) common stock have entered into agreements with Bristol-Myers Squibb (BMY) to support the transaction and to tender their shares in the offer. BMY says the acquisition builds on long-standing commitment to virology; gains full rights to promising Phase II hepatitis C biologic, pegylated-interferon lambda; obtains FDA-approved specialty surgical biologic, RECOTHROM; attains early clinical and pre-clinical programs in oncology and immunoscience. ZGEN is halted; BMY is down 0.3%. Price: 5.30, Change: 0, Percent Change: 0
http://www.midnighttrader.com
10/5/07 -- there are no coincidences here ...
oh and like many other longs .. not selling at this level --
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM